TERNGU IBILAH: Open Payments
NPI 1346761947 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 38 payments from 11 companies in 2025. Trend: 2023 $436 · 2024 $753 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $237 |
| Otsuka America Pharmaceutical, Inc. | 6 | $106 |
| Neurocrine BioSciences, Inc. | 5 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $87 |
| Alkermes, Inc. | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Corium, LLC | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| Tris Pharma Inc | 2 | $30 |
Products named: FANAPT, REXULTI, INGREZZA, INVEGA SUSTENNA, ARISTADA, CAPLYTA, Auvelity, Azstarys.
Industry payments across AL — which companies pay providers there.
